ARTICLE SUMMARY:
Certus has developed an endovascular aortic balloon catheter that functions automatically to sense and adjust the balloon volume to enable second-to-second control of blood pressure. This precision control will be the key to improved outcomes after hemorrhage, cardiac arrest, and stroke.
Medical device start-up Certus Critical Care Inc. is much farther along than you’d expect for a company seeking their first round of external equity investment. Founded in 2017, the company’s core hemorrhage control technology has been supported by almost $20 million in nondilutive funding from the Department of Defense to ensure that the company’s catheter and suite of other critical care devices gets to the wounded warfighters who may need it. According to Lucas Neff, MD, US Air Force Veteran, surgeon, and co-founder of Certus, hemorrhage is the number one cause of potentially preventable death on the battlefield.
